Sinew Pharma Balance Sheet

Financials in millions TWD. Fiscal year is January - December.

Millions TWD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	25.27	41.39	166.81	246.68	551.17
Short-Term Investments	1,027	1,118	1,109	1,144	931.49
Cash & Short-Term Investments	1,052	1,159	1,275	1,391	1,483
Cash Growth	-9.22%	-9.13%	-8.31%	-6.17%	338.25%
Accounts Receivable	0.05	-	-	-	-
Other Receivables	24.05	21.43	18.87	16.3	14.3
Receivables	24.1	21.43	18.87	16.3	14.3
Prepaid Expenses	1.16	0.78	0.52	0.63	4.22
Other Current Assets	-	-	0.57	-	-
Total Current Assets	1,077	1,181	1,295	1,408	1,501
Property, Plant & Equipment	17.05	7.12	18.86	14.35	4.51
Other Intangible Assets	15.44	22.27	38.51	55.58	67.23
Other Long-Term Assets	17.69	15.46	10.55	9.15	11.84
Total Assets	1,128	1,226	1,363	1,487	1,585
Accrued Expenses	16.06	18.33	22.9	15.36	10.56
Current Portion of Leases	5.97	2.82	6.46	2.99	1.05
Current Unearned Revenue	0.52	0.52	0.52	0.52	0.85
Other Current Liabilities	2.94	5.52	5.31	4.38	2.65
Total Current Liabilities	25.49	27.18	35.19	23.25	15.11
Long-Term Leases	9.23	-	2.82	4.56	-
Other Long-Term Liabilities	1.7	1.7	1.7	0.85	0.85
Total Liabilities	36.42	28.88	39.71	28.66	15.96
Common Stock	712.89	713.15	711.66	697.72	690.09
Additional Paid-In Capital	826.12	816.47	808.87	900.96	1,067
Retained Earnings	-445.04	-321.29	-170.92	-140.18	-188.43
Comprehensive Income & Other	-2.8	-11.07	-25.95	-	0.43
Shareholders' Equity	1,091	1,197	1,324	1,459	1,569
Total Liabilities & Equity	1,128	1,226	1,363	1,487	1,585
Total Debt	15.21	2.82	9.28	7.55	1.05
Net Cash (Debt)	1,037	1,156	1,266	1,384	1,482
Net Cash Growth	-10.32%	-8.68%	-8.48%	-6.61%	342.31%
Net Cash Per Share	14.59	16.21	17.97	19.97	24.90
Filing Date Shares Outstanding	71.29	71.31	71.17	69.77	69.01
Total Common Shares Outstanding	71.29	71.31	71.17	69.77	69.01
Working Capital	1,052	1,154	1,260	1,385	1,486
Book Value Per Share	15.31	16.79	18.60	20.90	22.73
Tangible Book Value	1,076	1,175	1,285	1,403	1,502
Tangible Book Value Per Share	15.09	16.48	18.06	20.11	21.76
Machinery	13.4	12.93	12.75	7.11	5.83
Leasehold Improvements	11.28	11.28	11.28	9.31	4.96

Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.